Andrew Grulich

Andrew Grulich is a prominent HIV researcher affiliated with the Kirby Institute in Australia, known for his work in epidemiology and public health. His research focuses on the prevention and treatment of HIV, contributing to significant advancements in the field, including studies on the effectiveness and accessibility of antiretroviral medications. Grulich has been vocal about the need for affordable HIV treatments, emphasizing the importance of making innovative drugs like lenacapavir accessible to populations at risk.